Cargando…
Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II–III Colorectal Cancer
Prospective identification of robust biomarkers related to prognosis and adjuvant chemotherapy has become a necessary and critical step to predict the benefits of adjuvant therapy for patients with stage II–III colorectal cancer (CRC) before clinical treatment. We proposed a single-cell-based progno...
Autores principales: | Wang, Zixuan, Xing, Kaiyuan, Zhang, Bo, Zhang, Yanru, Chai, Tengyue, Geng, Jingkai, Qin, Xuexue, Zhang, Xinxin, Xu, Chaohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604003/ https://www.ncbi.nlm.nih.gov/pubmed/36293319 http://dx.doi.org/10.3390/ijms232012460 |
Ejemplares similares
-
Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data
por: Xing, Kaiyuan, et al.
Publicado: (2023) -
ScRNA-seq and ST-seq in liver research
por: He, Jia, et al.
Publicado: (2023) -
scRNASequest: an ecosystem of scRNA-seq analysis, visualization, and publishing
por: Li, Kejie, et al.
Publicado: (2023) -
scDART: integrating unmatched scRNA-seq and scATAC-seq data and learning cross-modality relationship simultaneously
por: Zhang, Ziqi, et al.
Publicado: (2022) -
Computational approaches for interpreting scRNA‐seq data
por: Rostom, Raghd, et al.
Publicado: (2017)